Clinical Trials for BYL719

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1364
03/07/2014
A Phase Ib, Open-Label Study of Oral BGJ398 in Combination with Oral BYL719 in Adult Patients with Select Advanced Solid Tumors
TreatmentVICCPHI1065
02/01/2011
A phase IA, multicenter, open-label dose escalation study of oral BYL719, in adult patients with advanced solid malignancies, whose tumors have an alteration of the PIK3CA gene

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.